Neuromedical
PrivateLast Round
Seed
Feb 17, 2026
Total Funding Raised
$2.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neuromedical is a medical device company that develops VGuard, a non-invasive transcutaneous vagus nerve stimulation system designed for the treatment of mild cognitive impairment and early-stage Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuromedical Comparables
Compare Neuromedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| tVNS Technologies GmbH | 78% | |
| Cognito Therapeutics | 74% | |
| Vagustim | 66% | |
Neuromedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 17, 2026 | ||||
| Seed | May 20, 2025 | ||||
| Seed | May 17, 2020 |
Neuromedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INNOventure | Seed |
| Hard2beat | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
Raised $1.54M in a Seed round.
Neuromedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuromedical's valuation, stock price, and market status.